The extraordinary efficacy of platelet rich fibrin membrane on fungal infections of nails in a human model

Document Type : Research Paper

Authors

1 Iranian Tissue Bank & Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Surgery, Qom University of Medical Sciences, Qom, Iran

3 Iranian Tissue Bank & Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Fungal infections of nail can occur in people with brittle and dry skin. This condition can lead to nail damage and infection that spread beyond your feet if you have a suppressed immune system due to medication, diabetes or other conditions. If the immune system is suppressed due to medication, diabetes or other conditions, they expand. Some patients do not respond appropriately to common treatments. The use of platelet rich fibrin membrane (PRF M) has been suggested as an alternative method for fungal infection of nail treatment due to their potential to release many kinds of growth factors and antifungal efficacy.
Materials and Methods: The PRF M sample was obtained from the patient with fungal nail infection. PRF M was harvested from peripheral blood by centrifuging immediately. Moreover, PRF M was expanded over the damaged area in flat form five times for three days. Pre-treatment and post-treatment were then analyzed by observation of fungal infection.
Results: Visual observation showed the positive effect of this technique on the patient's recovery. Hence, it can be deduced that autologous PRF M is a promising safe therapy for drug-resistant fungal infections.
Conclusion: The present clinical case report demonstrated that PRF M may be able to remove fungal infections in human.

Keywords

References

  1. Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D. Topical and device-based treatments for fungal infections of the toenails. Cochrane Database of Systematic Reviews 2020; 16:1(1).
  2. Giudice A, Antonelli A, Muraca D, Fortunato L. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report. Indian Journal of Dental Research 2020; 31(5):813-818.
  3. Ghiasi M, Farzaneh S, Bigdelo M. Assessment of human cartilage regeneration in a patient with knee osteoarthritis using autologous adipose-tissue-derived stem cells and Platelet-rich plasma: a case study Journal of Surgery and Trauma 2020; 8(2):73-78. Journal of Surgery and Trauma 2020; 8(2):73-78.
  4. Naik B, Karunakar P, Jayadev M, Marshal VR. Role of platelet rich fibrin in wound healing: A critical review. Journal of Conservative Dentistry 2013; 16:284–93.
  5. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surgery, Oral Medicine, Oral Pathology Oral Radiology 2006; 101:e56–60.
  6. Lucarelli E, Beretta R, Dozza B, Tazzari PL, O'Connel SM, Ricci F, et al. A recently developed bifacial platelet-rich fibrin matrix. European Cells & Materials Journal 2010; 20:13–23.
  7. Inchingolo F, Cantore S, Dipalma G, Georgakopoulos I, Almasri M, Gheno E, et al. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation. Journal of Biological Regulators & Homeostatic Agents 2017; 31(3):811-816.
  8. Karde PA, Sethi KS, Mahale SA, Khedkar SU, Patil AG, Joshi CP. Comparative evaluation of platelet count and antimicrobial efficacy of injectable platelet-rich fibrin with other platelet concentrates: An in vitro study. Journal of Indian Society of Periodontology 2017; 21:97–101.
  9. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. Journal of Interferon & Cytokine Research 2002; 22:913–22.
  10. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infection and Immunity 2002; 70:6524–33.
  11. Ramadan A. Ali, Leah M. Wuescher, and Randall G. Platelets: essential components of the immune system. Current Trends in Immunology 2015; 16: 65–78.
  12. Yeaman MR, Tang YQ, Shen AJ, Bayer AS, Selsted ME. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infection and Immunity 1997; 65:1023–31.
  13. Toffler M, Toscano N, Holtzclaw D, Corso MD, Ehrenfest DD. Introducing Choukroun's platelet rich fibrin (PRF) to the reconstructive surgery milieu. Journal of Implant & Advanced Clinical Dentistry 2009; 1:21–30.
  14. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surgery, Oral Medicine, Oral Pathology Oral Radiology 2006; 101:e45–50.
  15. Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: New perspectives. Current Pharmaceutical Biotechnology 2012; 13:1153–62.
Journal of Basic and Clinical Pathophysiology
Volume 9, Issue 2
November 2021
Pages 11-14

Files

Share

How to cite

Statistics